van de Bovenkamp Hester M, Zuiderent-Jerak Teun
Institute of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Health Expect. 2015 Oct;18(5):942-55. doi: 10.1111/hex.12067. Epub 2013 May 2.
Patient participation on both the individual and the collective level attracts broad attention from policy makers and researchers. Participation is expected to make decision making more democratic and increase the quality of decisions, but empirical evidence for this remains wanting.
To study why problems arise in participation practice and to think critically about the consequence for future participation practices. We contribute to this discussion by looking at patient participation in guideline development.
Dutch guidelines (n = 62) were analysed using an extended version of the AGREE instrument. In addition, semi-structured interviews were conducted with actors involved in guideline development (n = 25).
The guidelines analysed generally scored low on the item of patient participation. The interviews provided us with important information on why this is the case. Although some respondents point out the added value of participation, many report on difficulties in the participation practice. Patient experiences sit uncomfortably with the EBM structure of guideline development. Moreover, patients who develop epistemic credibility needed to participate in evidence-based guideline development lose credibility as representatives for 'true' patients.
We conclude that other options may increase the quality of care for patients by paying attention to their (individual) experiences. It will mean that patients are not present at every decision-making table in health care, which may produce a more elegant version of democratic patienthood; a version that neither produces tokenistic practices of direct participation nor that denies patients the chance to contribute to matters where this may be truly meaningful.
患者在个体和集体层面的参与引起了政策制定者和研究人员的广泛关注。人们期望参与能使决策更加民主并提高决策质量,但对此的实证证据仍然不足。
研究参与实践中为何会出现问题,并对未来参与实践的后果进行批判性思考。我们通过研究患者在指南制定中的参与情况来为这一讨论做出贡献。
使用AGREE工具的扩展版本对荷兰的指南(n = 62)进行分析。此外,对参与指南制定的相关人员(n = 25)进行了半结构化访谈。
所分析的指南在患者参与项目上的得分普遍较低。访谈为我们提供了关于为何如此的重要信息。虽然一些受访者指出了参与的附加价值,但许多人报告了参与实践中的困难。患者的经验与指南制定的循证医学结构不太契合。此外,那些在参与循证指南制定中获得认知可信度的患者,作为“真正”患者的代表却失去了可信度。
我们得出结论,通过关注患者的(个体)经验,其他选择可能会提高患者的护理质量。这将意味着患者不会出现在医疗保健的每一个决策桌上,这可能会产生一个更优雅的民主患者模式;一种既不会产生直接参与的表面形式,也不会剥夺患者在真正有意义的事情上做出贡献机会的模式。